Naproxen and Hepatitis b antibody positive - a phase IV clinical study of FDA data

Summary:

Hepatitis b antibody positive is reported only by a few people who take Naproxen.

The phase IV clinical study analyzes which people take Naproxen and have Hepatitis b antibody positive. It is created by eHealthMe based on reports of 54,594 people who have side effects while taking Naproxen from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 29, 2022

54,594 people reported to have side effects when taking Naproxen.
Among them, 4 people (0.01%) have Hepatitis b antibody positive.


What is Naproxen?

Naproxen has active ingredients of naproxen. It is often used in pain. eHealthMe is studying from 57,542 Naproxen users for its effectiveness, alternative drugs and more.

What is Hepatitis b antibody positive?

Hepatitis b antibody positive is found to be associated with 358 drugs and 123 conditions by eHealthMe.

Number of Naproxen and Hepatitis b antibody positive reports submitted per year:

Could Naproxen cause Hepatitis b antibody positive?

Gender of people who have Hepatitis b antibody positive when taking Naproxen *:

  • female: 25 %
  • male: 75 %

Age of people who have Hepatitis b antibody positive when taking Naproxen *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 50 %
  • 50-59: 0.0 %
  • 60+: 50 %

Common drugs people take besides Naproxen *:

  1. Plaquenil: 3 people, 75.00%
  2. Vioxx: 2 people, 50.00%
  3. Prednisone: 2 people, 50.00%
  4. Otezla: 2 people, 50.00%
  5. Ciclosporin: 2 people, 50.00%
  6. Asa: 2 people, 50.00%
  7. Voltaren: 1 person, 25.00%
  8. Penicillamine: 1 person, 25.00%
  9. Hydroxychloroquine Sulfate: 1 person, 25.00%
  10. Arava: 1 person, 25.00%

Common side effects people have besides Hepatitis b antibody positive *:

  1. Hip Fracture: 2 people, 50.00%
  2. Liver Function Tests Nos Abnormal: 1 person, 25.00%
  3. Itching: 1 person, 25.00%
  4. Hepatitis B: 1 person, 25.00%
  5. Blood Bilirubin Increased: 1 person, 25.00%
  6. Biopsy Liver Abnormal: 1 person, 25.00%
  7. Bilirubinuria (presence of bilirubin in urine): 1 person, 25.00%

Common conditions people have *:

  1. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Naproxen and have Hepatitis b antibody positive?

Check whether Hepatitis b antibody positive is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Hepatitis b antibody positive and when was it recovered:

Expand to all the drugs that have ingredients of naproxen:

Alternative drugs to, pros and cons of Naproxen:

Common Naproxen side effects:

Browse all side effects of Naproxen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Hepatitis b antibody positive treatments and more:

COVID vaccines that are related to Hepatitis b antibody positive:

All the drugs that are associated with Hepatitis b antibody positive:

All the conditions that are associated with Hepatitis b antibody positive:

How the study uses the data?

The study uses data from the FDA. It is based on naproxen (the active ingredients of Naproxen) and Naproxen (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: